Title |
The management of bleeding in patients hospitalised in the intensive cardio care unit / |
Translation of Title |
The Management of Bleeding in Patients Hospitalised in the Intensive Cardio Care Unit. |
Authors |
Philipsen, Lea |
Full Text |
|
Pages |
23 |
Keywords [eng] |
Intensive cardio care unit, Bleeding, ACS, CVD, Antiplatlet therapy, Anticoagulation, BARC, TIMI, GUSTO, modifiable risk factors, non-modifiable risk fators |
Abstract [eng] |
Patients treated in the intensive cardio care unit have an increased risk profile and are more susceptible to further morbidity due to comorbidities and existing long-term medications. In cardiology, risk stratification scores based on risk factors are used to select the most appropriate management. Anticoagulants and antiplatelet agents are cornerstones of cardiology and comprehensively used. However, in the case of bleeding events, they are also non-modifiable risk factors. Evidence suggests that bleeding increases all-cause mortality in the same way as recurrent myocardial infarction. As a result, they have equivalent prognostic significance. In particular, the first 30 days are decisive for the subsequent treatment outcome. As a result, bleeding and the associated risk characteristics of the patient population need to be given the same attention as the risk of other life-threatening cardiac events when determining further management. |
Dissertation Institution |
Vilniaus universitetas. |
Type |
Master thesis |
Language |
English |
Publication date |
2023 |